AAAAAA

   
Results: 1-25 | 26-40 |
Results: 26-40/40

Authors: Eltabbakh, GH
Citation: Gh. Eltabbakh, Small bowel obstruction secondary to herniation through a 5-mm laparoscopic trocar site following laparoscopic lymphadenectomy, EUR J GYN O, 20(4), 1999, pp. 275-276

Authors: Eltabbakh, GH Moody, J Garafano, LL Hammond, JM
Citation: Gh. Eltabbakh et al., The combination paclitaxel, carboplatin and megestrol acetate is effectivein women with recurrent uterine papillary serous adenocarcinoma, EUR J GYN O, 20(1), 1999, pp. 18-19

Authors: Werness, BA Afify, AM Eltabbakh, GH Huelsman, K Piver, MS Paterson, JM
Citation: Ba. Werness et al., p53, c-erbB, and Ki-67 expression in ovaries removed prophylactically fromwomen with a family history of ovarian cancer, INT J GYN P, 18(4), 1999, pp. 338-343

Authors: Piver, MS Ghamande, SA Eltabbakh, GH O'Neill-Coppola, C
Citation: Ms. Piver et al., First-line chemotherapy with paclitaxel and platinum for advanced and recurrent cancer of the cervix - A phase II study, GYNECOL ONC, 75(3), 1999, pp. 334-337

Authors: Eltabbakh, GH Yadev, PR Morgan, A
Citation: Gh. Eltabbakh et al., Clinical picture of women with early stage ovarian cancer, GYNECOL ONC, 75(3), 1999, pp. 476-479

Authors: Eltabbakh, GH Piver, MS Hempling, RE Recio, FO Paczos, T
Citation: Gh. Eltabbakh et al., Analysis of failed and complicated laparoscopy on a gynecologic oncology service, GYNECOL ONC, 74(3), 1999, pp. 477-482

Authors: Eltabbakh, GH Moore, AD
Citation: Gh. Eltabbakh et Ad. Moore, Survival of women with surgical stage II endometrial cancer, GYNECOL ONC, 74(1), 1999, pp. 80-85

Authors: Eltabbakh, GH Natarajan, N Piver, MS Mettlin, CJ
Citation: Gh. Eltabbakh et al., Epidemiologic differences between women with borderline ovarian tumors andwomen with epithelial ovarian cancer, GYNECOL ONC, 74(1), 1999, pp. 103-107

Authors: Eltabbakh, GH
Citation: Gh. Eltabbakh, Do human normal somatic cells lack telomerase activity? Reply, GYNECOL ONC, 74(1), 1999, pp. 149-150

Authors: Eltabbakh, GH Piver, MS
Citation: Gh. Eltabbakh et Ms. Piver, Concerns with "maintenance chemotherapy" for patients with recurrent platinum-sensitive ovarian cancer - Reply, GYNECOL ONC, 73(3), 1999, pp. 470-472

Authors: Werness, BA Afify, AM Bielat, KL Eltabbakh, GH Piver, MS Paterson, JM
Citation: Ba. Werness et al., Altered surface and cyst epithelium of ovaries removed prophylactically from women with a family history of ovarian cancer, HUMAN PATH, 30(2), 1999, pp. 151-157

Authors: Eltabbakh, GH Piver, MS Hempling, RE Recio, FO Paczos, T
Citation: Gh. Eltabbakh et al., Laparoscopic management of women with a family history of ovarian cancer, J SURG ONC, 72(1), 1999, pp. 9-13

Authors: Eltabbakh, GH Piver, MS Hempling, RE Recio, FO Intengen, ME
Citation: Gh. Eltabbakh et al., Clinical picture, response to therapy, and survival of women with diffuse malignant peritoneal mesothelioma, J SURG ONC, 70(1), 1999, pp. 6-12

Authors: Eltabbakh, GH Piver, MS Hempling, RE Recio, FO Blumenson, LE
Citation: Gh. Eltabbakh et al., Prolonged disease-free survival by maintenance chemotherapy among patientswith recurrent platinum-sensitive ovarian cancer, GYNECOL ONC, 71(2), 1998, pp. 190-195

Authors: Eltabbakh, GH Werness, BA Piver, S Blumenson, LE
Citation: Gh. Eltabbakh et al., Prognostic factors in extraovarian primary peritoneal carcinoma, GYNECOL ONC, 71(2), 1998, pp. 230-239
Risultati: 1-25 | 26-40 |